Estrogen and combined estrogen-progestogen therapy in the menopause and breast cancer

Breast

Volumn 13, Issue 6, 2004, Pages 515-518

  La Vecchia, Carlo ^a,b  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Breast cancer; Hormone therapy; Menopause; Risk

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; ESTROGEN; GESTAGEN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CARCINOGENICITY; CASE CONTROL STUDY; CLINICAL TRIAL; CONFIDENCE INTERVAL; CORRELATION ANALYSIS; FEMALE; FOLLOW UP; HORMONAL THERAPY; HUMAN; MENOPAUSE; POPULATION DISTRIBUTION; POPULATION RESEARCH; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK; RISK ASSESSMENT; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

EID: 10244267659     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.breast.2004.07.006     Document Type: Article

References (30)

1. Collaborative Group on Hormonal Factors in Breast Cancer Breast cancer and hormone replacement therapy: Collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer Lancet 350 1997 1047-1059
2. V. Beral E. Banks G. Reeves P. Appleby Use of HRT and the subsequent risk of cancer J Epidemiol Biostat 4 1999 191-215
3. C. La Vecchia S. Franceschi Hormone replacement therapy and cancer: An update Eur J Cancer Prevent 12 2003 3-4
4. C. La Vecchia Menopause, hormone therapy and breast cancer risk Eur J Cancer Prevent 12 2003 437-438
5. C. La Vecchia L.A. Brinton A. McTiernan Menopause, hormone replacement therapy and cancer Maturitas 39 2001 97-115
6. G.A. Colditz S.E. Hankinson D.J. Hunter et al. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women N Engl J Med 332 1995 1589-1593
7. C. Magnusson J.A. Baron N. Correia et al. Breast-cancer risk following long-term oestrogen- and oestrogen-progestin-replacement therapy Int J Cancer 81 1999 339-344
8. C. Schairer J. Lubin R. Troisi S. Sturgeon L. Brinton R. Hoover Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk J Am Med Assoc 283 2000 485-491
9. R.K. Ross A. Paganini-Hill P.C. Wan M.C. Pike Effect of hormone replacement therapy on breast cancer risks: Estrogen versus estrogen plus progestin J Natl Cancer Inst 92 2000 328-332
10. H.L. Olsson C. Ingvar A. Bladstrom Hormone replacement therapy containing progestins and given continuously increases breast carcinoma risk in Sweden Cancer 97 2003 1387-1392
11. H. Jernstrom O. Bendahl P- J. Lidfeldt C. Nerbrand D. Agardh C- G. Samsioe A prospective study of different types of hormone replacement therapy use and the risk of subsequent breast cancer: The women's health in the Lund area (WHILA) study (Sweden) Cancer Causes Control 14 2003 673-680
12. L.K. Weiss R.T. Burkman K.L. Cushing-Haugen et al. Hormone replacement therapy regimens and breast cancer risk Obstet Gynecol 100 2002 1148-1158
13. G.A. Greendale B.A. Reboussin S. Slone C. Wasilauskas M.C. Pike G. Ursin Postmenopausal hormone therapy and change in mammographic density J Natl Cancer Inst 95 2003 30-37
14. J.V. Porch M. Lee I- N.R. Cook K.M. Rexrode J.E. Buring Estrogen-progestin replacement therapy and breast cancer risk: The Women's Health Study (United States) Cancer Causes Control 13 2002 847-854
15. C. Li K.E. Malone P.L. Porter et al. Relationship between long durations and different regiments of hormone therapy and risk of breast cancer J Am Med Assoc 289 2003 3254-3263
16. H.M. Verkooijen G. Fioretta G. Vlastos et al. Important increase of invasive lobular breast cancer incidence in Geneva, Switzerland Int J Cancer 104 2003 778-781
17. F. Levi C. Te V- L. Randimbison C. La Vecchia Increase in lobular breast cancer incidence in Switzerland Int J Cancer 107 2003 164-165
18. Million Women Study Collaborators Breast cancer and hormone-replacement therapy in the Million Women Study Lancet 362 2003 419-427
19. C. Stahlberg A.T. Pedersen E. Lynge et al. Increased risk of breast cancer following different regimens of hormone replacement therapy frequently used in Europe Int J Cancer 109 2004 721-727
20. Writing Group for the Women's Health Initiative Investigators Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial J Am Med Assoc 288 2002 321-333
21. T.M. Powledge NIH terminates WHI oestrogen-only study Lancet 363 2004 870
22. Women's Health Initiative Steering Committee Effects of conjugated equine estrogen in postmenopausal women with hysterectomy J Am Med Assoc 291 2004 1701-1712
23. S. Hulley C. Furberg E. Barrett-Connor et al. Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II) J Am Med Assoc 288 2002 58-66
24. C.M. Viscoli L.M. Brass W.N. Kernan P.M. Sarrel S. Suissa R.I. Horwitz A clinical trial of estrogen-replacement therapy after ischemic stroke N Engl J Med 345 2001 1243-1249
25. V. Beral E. Banks G. Reeves Evidence from randomised trials on the long-term effects of hormone replacement therapy Lancet 360 2002 942-944
26. S.B. Hulley D. Grady The WHI estrogen-alone trial. Do things look any better? J Am Med Assoc 291 2004 1769-1771
27. C. Rodriguez E.E. Calle A.V. Patel L.M. Tatham E.J. Jacobs M.J. Thun Effect of body mass on the association between estrogen replacement therapy and mortality among elderly US women Am J Epidemiol 153 2001 145-152
28. R.T. Chlebowski S.L. Hendrix R.D. Langer et al. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women J Am Med Assoc 289 2003 3243-3253
29. L. Holmberg H. Anderson for the HABITS steering and data monitoring committees Lancet 363 2004 453-455
30. R.T. Chlebowski N. Col Menopausal hormone therapy after breast cancer Lancet 363 2004 410-411